+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronaviruses and other Novel Antiviral Targets. Annual Reports in Medicinal Chemistry Volume 57

  • Book

  • November 2021
  • Elsevier Science and Technology
  • ID: 5342507

Annual Reports in Medicinal Chemistry, Volume 57 in this long-running series, highlights new advances in the field with this new volume presenting interesting chapters on the Mechanism of action of the broadly acting antiviral drug remdesivir, Improving properties of the nucleobase analogue T-706 as a potential anti-SARS-CoV-2 and anti-influenza compound, Antivirals for RNA virus infections Anno 2020-2021, Broad spectrum antiviral fleximer nucleosides, SARS-CoV-2 main protease inhibitors, The search for antivirals to treat alphavirus infections, Inhibitors of Ebola Virus targeting Innate immune evasion, Uracil derivatives as non-nucleoside inhibitors of viral infections, and more.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Improving properties of the nucleobase analogs T-705/T-1105 as potential antivirals

2. Anno 2021: Which antivirals for the coming decade?

3. Broad spectrum antiviral fleximer nucleosides

4. The search for antivirals to treat alphavirus infections

5. Inhibitors of Ebola Virus targeting Innate immune evasion

6. Uracil derivatives as non-nucleoside inhibitors of viral infections